Valiant Labs: Rights Issue Funds Utilized Appropriately for Q2 2026
Valiant Laboratories Ltd has submitted its Monitoring Agency Report for the quarter ended June 30, 2026. The report, issued by India Ratings and Research Private Limited, confirms that funds raised through the company's Rights Issue, as detailed in the Letter of Offer dated July 15, 2025, have been utilized appropriately for the stated objects. No deviation from the objects of the issue was observed, as verified by a Statutory Auditor Certificate. The report has been reviewed by the Audit Committee and the Board of Directors.
Key Highlights
- Rights issue proceeds utilized as per offer document.
- No deviation from stated objects confirmed by monitoring agency.
- Statutory Auditor and Board have reviewed the utilization.
- Report covers utilization for the quarter ended June 30, 2026.
Price Impact
More from VALIANTLAB
Valiant Labs Approves ₹60 Cr Investment in Subsidiary, Director Reappointments
Valiant Labs Re-appoints MD, Independent Director; Approves Office Shift
Valiant Labs Shifts Registered Office, Approves Director Re-appointments